Grants

PI Name Sort ascending PI Organization Title Grant Number Initiative Program Director
Sharafeldin, Noha

University Of Alabama At Birmingham
United States

A multi-component non-pharmacological intervention to improve cognitive outcomes in hematologic cancer survivors 1R03CA270671-01 Diane St Germain, R.N., M.S., C.R.N.P.
Sehgal, Ashwini

Case Western Reserve University
United States

Pain and Immobility After Breast Cancer Surgery: A Community-Based Randomized Controlled Trial of Myofascial Massage Treatment 5R01CA229287-03 Diane St Germain, R.N., M.S., C.R.N.P.
Sedrak, Mina S

Beckman Research Institute/City Of Hope
United States

Using Senolytics to Improve Physical Function in Older Breast Cancer Survivors 1R21CA277660-01 Diane St Germain, R.N., M.S., C.R.N.P.
Schwartz, Gary K

Columbia University Health Sciences
United States

Columbia University Minority/Underserved Site NCI Community Oncology Research Program 5UG1CA189960-09 Worta McCaskill-Stevens, M.D., M.S.
Schenker, Yael

University Of Pittsburgh At Pittsburgh
United States

A cluster randomized trial of a primary palliative care intervention (CONNECT) for patients with advanced cancer 5R01CA197103-06 Diane St Germain, R.N., M.S., C.R.N.P.
Schallenkamp, John M.

Montana Cancer Consortium
United States

Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming 5UG1CA189872-09 Worta McCaskill-Stevens, M.D., M.S.
Saphner, Thomas J

Aurora Health Care, Inc.
United States

Aurora NCORP Community Site 5UG1CA190140-09 Worta McCaskill-Stevens, M.D., M.S.
Sanft, Tara B

Yale University
United States

A randomized trial of lifestyle guidelines on breast cancer biomarkers and treatment adherence 5R01CA207753-05 Diane St Germain, R.N., M.S., C.R.N.P.
Salvemini, Daniela

Saint Louis University
United States

Fingolimod and Ozanimod for the treatment and prevention of chemobrain 1R01CA261979-01A1 PAR-19-325 (R01 Clinical Trial Optional) Diane St Germain, R.N., M.S., C.R.N.P.
Salvemini, Daniela

Saint Louis University
United States

Fingolimod and Ozanimod for the treatment and prevention of chemobrain 1R01CA261979-01A1 PAR-19-325 (R01 Clinical Trial Optional) Diane St Germain, R.N., M.S., C.R.N.P.